نتائج البحث - Jeffrey Eastham‐Anderson

  • يعرض 1 - 19 نتائج من 19
تنقيح النتائج
  1. 1
    MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length

    MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length حسب K. Jessica, Mia Y. Platt, Jeffrey Eastham‐Anderson, Jeoung‐Sook Shin, Ira Mellman

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis

    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis حسب James Ziai, Houston Gilbert, Oded Foreman, Jeffrey Eastham‐Anderson, Felix Chu, Mahrukh Huseni, Jeongmin Kim

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways

    FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways حسب Ai-Luen Wu, Sally Coulter, Christopher Liddle, Anne Wong, Jeffrey Eastham‐Anderson, Dorothy French, Andrew S. Peterson, Junichiro Sonoda

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice

    The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice حسب Jonathan Sitrin, Eric Suto, Arthur Wüster, Jeffrey Eastham‐Anderson, Jeong Kim, Cary D. Austin, Wyne P. Lee, Timothy W. Behrens

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors

    Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors حسب Bijay S. Jaiswal, Vasantharajan Janakiraman, Noelyn M. Kljavin, Jeffrey Eastham‐Anderson, James Cupp, Yuxin Liang, David P. Davis, Klaus P. Hoeflich, Somasekar Seshagiri

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury

    DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury حسب Trent A. Watkins, Bei Wang, Sarah Huntwork‐Rodriguez, Jing Yang, Zhiyu Jiang, Jeffrey Eastham‐Anderson, Zora Modrušan, Joshua S. Kaminker, Marc Tessier‐Lavigne, Joseph W. Lewcock

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    In vivo quantification of murine aortic cyclic strain, motion, and curvature: Implications for abdominal aortic aneurysm growth

    In vivo quantification of murine aortic cyclic strain, motion, and curvature: Implications for abdominal aortic aneurysm growth حسب Craig J. Goergen, Kyla N. Barr, Diem Thi Ngoc Huynh, Jeffrey Eastham‐Anderson, Gilwoo Choi, Maj Hedehus, Ronald L. Dalman, Andrew J. Connolly, Charles A. Taylor, Philip S. Tsao, Joan Greve

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Transcription factor Etv5 is essential for the maintenance of alveolar type II cells

    Transcription factor Etv5 is essential for the maintenance of alveolar type II cells حسب Zhen Zhang, Kim Newton, Sarah Kummerfeld, Joshua D. Webster, Donald S. Kirkpatrick, Lilian Phu, Jeffrey Eastham‐Anderson, Jinfeng Liu, Wyne P. Lee, Jian-Sheng Wu, Hong Li, Melissa R. Junttila, Vishva M. Dixit

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity

    B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity حسب Martin S. Weber, Thomas Prod’homme, Juan C. Patarroyo, Nicolas Molnarfi, Tara Karnezis, Klaus Lehmann‐Horn, Dimitry M. Danilenko, Jeffrey Eastham‐Anderson, Anthony Slavin, Christopher Linington, Claude C.A. Bernard, Flavius Martin, Scott S. Zamvil

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab

    Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab حسب Evelyn Yao, Wei Zhou, Si Tuen Lee-Hoeflich, Tom Truong, Peter M. Haverty, Jeffrey Eastham‐Anderson, Nicholas Lewin‐Koh, Bert Gunter, Marcia Belvin, Lesley Murray, Lori S. Friedman, Mark X. Sliwkowski, Klaus P. Hoeflich

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model

    Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model حسب Danielle Mandikian, Nene Takahashi, Sadis Matalon, Ji Li, Jeffrey Eastham‐Anderson, Dionysos Slaga, Jason Ho, Maria Hristopoulos, Robyn Clark, Klára Tótpál, Kedan Lin, Sean B. Joseph, Mark S. Dennis, Saileta Prabhu, Teemu T. Junttila, C. Andrew Boswell

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult

    Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult حسب Martin Larhammar, Sarah Huntwork‐Rodriguez, Zhiyu Jiang, Hilda Solanoy, Arundhati Sengupta Ghosh, Bei Wang, Joshua S. Kaminker, Kevin Huang, Jeffrey Eastham‐Anderson, Michael Siu, Zora Modrušan, Madeline M. Farley, Marc Tessier‐Lavigne, Joseph W. Lewcock, Trent A. Watkins

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes

    Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes حسب Jeffrey J. Wallin, Jane Guan, Kyle A. Edgar, Wei Zhou, Ross S. Francis, Anthony C. Torres, Peter M. Haverty, Jeffrey Eastham‐Anderson, Sabrina Arena, Alberto Bardelli, Sue Griffin, Jane Goodall, Kyla M. Grimshaw, Klaus P. Hoeflich, C Torrance, Marcia Belvin, Lori S. Friedman

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    IL-33 amplifies an innate immune response in the degenerating retina

    IL-33 amplifies an innate immune response in the degenerating retina حسب Hongkang Xi, Kenneth J. Katschke, Yun Li, Tom Truong, Wyne P. Lee, Lauri Diehl, Linda Rangell, Jianhua Tao, Rommel Arceo, Jeffrey Eastham‐Anderson, Jason A. Hackney, Antonio Iglesias, Javier Cote-Sierra, Justin Elstrott, Robby M. Weimer, Menno van Lookeren Campagne

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    PPM1H Is a p27 Phosphatase Implicated in Trastuzumab Resistance

    PPM1H Is a p27 Phosphatase Implicated in Trastuzumab Resistance حسب Si Tuen Lee-Hoeflich, Thinh Q. Pham, Don Dowbenko, Xander Munroe, James Lee, Li Li, Wei Zhou, Peter M. Haverty, Kanan Pujara, Jeremy Stinson, Sara M. Chan, Jeffrey Eastham‐Anderson, Ajay Pandita, Somasekar Seshagiri, Klaus P. Hoeflich, Gulisa Turashvili, Karen A. Gelmon, Samuel Aparício, David P. Davis, Mark X. Sliwkowski, Howard M. Stern

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth

    PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth حسب Carlos Bais, Xiumin Wu, Jenny Yao, Suya Yang, Yongping Crawford, Krista McCutcheon, Christine Tan, Ganesh Kolumam, Jean-Michel Vernes, Jeffrey Eastham‐Anderson, Peter C. Haughney, Marcin Kowanetz, Thijs J. Hagenbeek, Ian Kasman, Hani Bou Reslan, Jed Ross, Nick van Bruggen, Richard A.D. Carano, Yu-Ju Gloria Meng, Jo-Anne Hongo, Jean Philippe Stephan, Masabumi Shibuya, Napoleone Ferrara

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors

    Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors حسب Mark Merchant, John G. Moffat, Gabriele Schaefer, Jocelyn Chan, Xi Wang, Christine Orr, Jason Cheng, Thomas Hunsaker, Lily Shao, Stephanie J. Wang, Marie-Claire Wagle, Eva Lin, Peter M. Haverty, Sheerin Shahidi-Latham, Hai Ngu, Margaret Solon, Jeffrey Eastham‐Anderson, Hartmut Koeppen, Shih-Min A. Huang, Jacob B. Schwarz, Marcia Belvin, Daniel C. Kirouac, Melissa R. Junttila

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

    Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial حسب Séverine Vermeire, Sharon O’Byrne, Mary Keir, Marna Williams, Timothy T. Lu, John Mansfield, Christopher A Lamb, Brian G. Feagan, Julián Panés, Azucena Salas, Daniel C. Baumgart, Stefan Schreiber, Iris Dotan, William J. Sandborn, Gaik W. Tew, Diana Luca, Meina Tang, Lauri Diehl, Jeffrey Eastham‐Anderson, Gert De Hertogh, Clémentine Perrier, Jackson G. Egen, John A. Kirby, Gert Van Assche, Paul Rutgeerts

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)

    Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax) حسب Joel D. Leverson, H Zhang, J Chen, Sajid Khan Tahir, Darren C. Phillips, John Xue, Paul Nimmer, Sha Jin, Morey L. Smith, Yu Xiao, Peter Kovar, Atsushi Tanaka, Milan Bruncko, George S. Sheppard, Longcheng Wang, Sarah Gierke, Lorn Kategaya, Daniel J. Anderson, Chihunt Wong, Jeffrey Eastham‐Anderson, Mary J. C. Ludlam, Deepak Sampath, Wayne J. Fairbrother, Ingrid E. Wertz, S.H. Rosenberg, Christin Tse, Steven W. Elmore, Andrew J. Souers

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: